Fracture Healing Complication (FHC) in Women with Postmenopausal Osteoporosis (PMO) Exposed to Bisphosphonate (BP) versus Other or No Osteoporosis Medication (OPM)

Sep-15

Musculoskeletal Pharmacoepidemiology Women's Health

AUTHORS : Fei Xue, Center for Observational Research, Amgen Inc., One Amgen Center Drive, MS 24-2-C, Thousand Oaks, CA 91320, USA – Email: fxue@amgen.com

JOURNAL : Pharmacoepidemiology and Drug Safety

REFERENCE: 24(S1):553-554

DOI : 10.1002/pds.3838

Read more

More publications

Apr-25

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Diabetes Pharmacoepidemiology

Read more

Feb-25

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement

Pharmacoepidemiology Rheumatology

Read more

Feb-25

Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort study

Pharmacoepidemiology Rheumatology

Read more